Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 254


Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine.

Tong J, Fitzmaurice PS, Moszczynska A, Rathitharan G, Ang LC, Meyer JH, Mizrahi R, Boileau I, Furukawa Y, McCluskey T, Sailasuta N, Kish SJ.

Drug Alcohol Depend. 2018 Jun 23;190:20-28. doi: 10.1016/j.drugalcdep.2018.05.021. [Epub ahead of print]


Comparative hazards of acute myocardial infarction among hospitalized patients with methamphetamine- or cocaine-use disorders: A retrospective cohort study.

Callaghan RC, Halliday M, Gatley J, Sykes J, Taylor L, Benny C, Kish SJ.

Drug Alcohol Depend. 2018 Jul 1;188:259-265. doi: 10.1016/j.drugalcdep.2018.03.030. Epub 2018 Apr 26.


Elevated monoamine oxidase A activity and protein levels in rodent brain during acute withdrawal after chronic intermittent ethanol vapor exposure.

Matthews BA, Tong J, Attwells S, Xu X, Le A, Kish SJ, Meyer JH.

Drug Alcohol Depend. 2018 Apr 1;185:398-405. doi: 10.1016/j.drugalcdep.2017.11.036. Epub 2018 Feb 5.


Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.

Tong J, Rathitharan G, Meyer JH, Furukawa Y, Ang LC, Boileau I, Guttman M, Hornykiewicz O, Kish SJ.

Brain. 2017 Sep 1;140(9):2460-2474. doi: 10.1093/brain/awx172.


Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder.

Attwells S, Setiawan E, Wilson AA, Rusjan PM, Mizrahi R, Miler L, Xu C, Richter MA, Kahn A, Kish SJ, Houle S, Ravindran L, Meyer JH.

JAMA Psychiatry. 2017 Aug 1;74(8):833-840. doi: 10.1001/jamapsychiatry.2017.1567.


Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications.

Sitte HH, Pifl C, Rajput AH, Hörtnagl H, Tong J, Lloyd GK, Kish SJ, Hornykiewicz O.

Eur J Neurosci. 2017 May;45(10):1356. doi: 10.1111/ejn.13573. No abstract available.


Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls.

Rabin RA, Barr MS, Goodman MS, Herman Y, Zakzanis KK, Kish SJ, Kiang M, Remington G, George TP.

Neuropsychopharmacology. 2017 Oct;42(11):2259-2271. doi: 10.1038/npp.2017.85. Epub 2017 Apr 26.


Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications.

Sitte HH, Pifl C, Rajput AH, Hörtnagl H, Tong J, Lloyd GK, Kish SJ, Hornykiewicz O.

Eur J Neurosci. 2017 Jan;45(1):192-197. doi: 10.1111/ejn.13435. Epub 2016 Nov 11. Erratum in: Eur J Neurosci. 2017 May;45(10 ):1356.


Inhibition of fatty acid amide hydrolase by BIA 10-2474 in rat brain.

Tong J, Mizrahi R, Houle S, Kish SJ, Boileau I, Nobrega J, Rusjan PM, Wilson AA.

J Cereb Blood Flow Metab. 2017 Nov;37(11):3635-3639. doi: 10.1177/0271678X16668890. Epub 2016 Oct 1.


Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence.

Kish SJ, Boileau I, Callaghan RC, Tong J.

Eur J Neurosci. 2017 Jan;45(1):58-66. doi: 10.1111/ejn.13363. Epub 2016 Sep 5. Review.


A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia.

Furukawa Y, Rajput AH, Tong J, Tomizawa Y, Hornykiewicz O, Kish SJ.

Neurology. 2016 Sep 6;87(10):1060-1. doi: 10.1212/WNL.0000000000003065. Epub 2016 Aug 3. No abstract available.


Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users.

Boileau I, Payer D, Rusjan PM, Houle S, Tong J, McCluskey T, Wilson AA, Kish SJ.

Neuropsychopharmacology. 2016 Dec;41(13):2994-3002. doi: 10.1038/npp.2016.108. Epub 2016 Jun 29.


Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB.

Boileau I, Mansouri E, Williams B, Le Foll B, Rusjan P, Mizrahi R, Tyndale RF, Huestis MA, Payer DE, Wilson AA, Houle S, Kish SJ, Tong J.

Biol Psychiatry. 2016 Nov 1;80(9):691-701. doi: 10.1016/j.biopsych.2016.04.012. Epub 2016 Apr 25.


Do glutathione levels decline in aging human brain?

Tong J, Fitzmaurice PS, Moszczynska A, Mattina K, Ang LC, Boileau I, Furukawa Y, Sailasuta N, Kish SJ.

Free Radic Biol Med. 2016 Apr;93:110-7. doi: 10.1016/j.freeradbiomed.2016.01.029. Epub 2016 Feb 1.


D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia.

Payer DE, Guttman M, Kish SJ, Tong J, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I.

Neurology. 2016 Jan 19;86(3):224-30. doi: 10.1212/WNL.0000000000002285. Epub 2015 Dec 30.


Personality disorder symptomatology is associated with anomalies in striatal and prefrontal morphology.

Payer DE, Park MT, Kish SJ, Kolla NJ, Lerch JP, Boileau I, Chakravarty MM.

Front Hum Neurosci. 2015 Aug 31;9:472. doi: 10.3389/fnhum.2015.00472. eCollection 2015.


Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence.

Boileau I, McCluskey T, Tong J, Furukawa Y, Houle S, Kish SJ.

Neuropsychopharmacology. 2016 Mar;41(4):1179-87. doi: 10.1038/npp.2015.267. Epub 2015 Aug 31.


Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors.

Chiuccariello L, Cooke RG, Miler L, Levitan RD, Baker GB, Kish SJ, Kolla NJ, Rusjan PM, Houle S, Wilson AA, Meyer JH.

Int J Neuropsychopharmacol. 2015 Aug 27;19(1). pii: pyv078. doi: 10.1093/ijnp/pyv078.


Differential cardiovascular and hypothalamic pituitary response to amphetamine in male pathological gamblers versus healthy controls.

Zack M, Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA, Warsh JJ, Kish SJ.

J Psychopharmacol. 2015 Sep;29(9):971-82. doi: 10.1177/0269881115592338. Epub 2015 Jul 7.


Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.

Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ.

Neurobiol Dis. 2015 Oct;82:243-253. doi: 10.1016/j.nbd.2015.06.010. Epub 2015 Jun 21.

Supplemental Content

Support Center